Baselaunch visual pills

BaseLaunch visual pills


Accelerating Therapeutic Ventures

We partner with scientist and entrepreneurs to help build biopharma ventures from scratch, getting the companies off the ground and financed. And we know how to do this – so far, our portfolio companies have raised over 100 million USD in financing.

What we do:

Grants for startups
Up to 500,000 USD in financing
Industry access for healthcare startups
Access to partners & network
Insights biotech and pharma ecosystem
Company & team build out
Infrastructure and laboratories healthcare startups
Access to infrastructure

Partner updates will be announced soon.

Johnson & Johnson Innovation Logo
Novartis Venture Fund Logo
Pfizer Logo
Roivant
“We are pleased to help energize the Basel region’s center of gravity for European healthcare ventures, offering startups the support they need to accelerate their ideas.”

Dr. Anja König, Global Head, Novartis Venture Fund

“Through Pfizer’s support of BaseLaunch, we hope to advance the pace at which promising science is translated into potential medicines.”

Uwe Schoenbeck, Chief Scientific Officer, External Research and Development Innovation & Senior Vice President, Worldwide Research and Development, Pfizer

“This program offers grants and lab space to selected startups – with no strings attached – illustrating that what we want to create here is an optimal environment for startups that focuses on supporting transformative science and great ideas in Switzerland.”

Richard Mason, Head of the Johnson & Johnson London Innovation Centre

“Through our partnership, we help build a unique and powerful platform to connect academia and entrepreneurs with leading healthcare companies and proven industry veterans: a great opportunity for the Basel region, its outstanding talents and Roivant.”

Sascha Bucher, VP and Head of Global Transactions, Roivant

“We are pleased to help energize the Basel region’s center of gravity for European healthcare ventures, offering startups the support they need to accelerate their ideas.”

Dr. Anja König, Global Head, Novartis Venture Fund

“Through Pfizer’s support of BaseLaunch, we hope to advance the pace at which promising science is translated into potential medicines.”

Uwe Schoenbeck, Chief Scientific Officer, External Research and Development Innovation & Senior Vice President, Worldwide Research and Development, Pfizer

“This program offers grants and lab space to selected startups – with no strings attached – illustrating that what we want to create here is an optimal environment for startups that focuses on supporting transformative science and great ideas in Switzerland.”

Richard Mason, Head of the Johnson & Johnson London Innovation Centre

“Through our partnership, we help build a unique and powerful platform to connect academia and entrepreneurs with leading healthcare companies and proven industry veterans: a great opportunity for the Basel region, its outstanding talents and Roivant.”

Sascha Bucher, VP and Head of Global Transactions, Roivant

News & Events

T3 Pharma, a spin-off of the University of Basel and one of our portfolio, has raised over $12 million from Boehringer Ingelheim Venture Fund and Refe...

Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds towards expanding its te...

The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners a...

Anaveon, a Basel-based immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joi...

A strong and compelling pitch of your science is critical for your company’s survival.                                      ...

In preparation for the second Redefining Early Stage Investments (RESI) conference to be held in Europe, Life Science Nation (LSN) and Venture Valuati...

From our partner, KPGM: The rules of engagement in the global pharmaceutical industry are changing rapidly with disruption in this industry already we...

Lessons learned by startup founders Do you have an idea that could change the world? Is your project providing an innovative solution and holds the po...

The selection committee has chosen 15 promising projects for Phase I. The projects all focus on developing innovative technologies to dramat...

There are many obstacles to the first launch of a drug in the European markets, even more for non-European biopharmaceutical companies. One needs to c...

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its ...